Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control
Condition(s) studied
Investigational drug(s) / intervention(s)
Boston Scientific WaveWriter Alpha™ SCS Systems: Time Varied Pulse (TVP)-SCS settings
Study summary
Study to evaluate the effectiveness of time variant pulse (TVP)-SCS in patients with chronic pain using commercially approved Boston Scientific SCS Systems per local Instructions for use (IFU).
In addition, to compile real-world clinical outcomes in subjects with chronic, intractable low back and/or leg pain.
Eligibility
Primary outcome measure(s)
- Targeted Pain Responder Rate — 3 months post-activation
Proportion of subjects with 50% or greater reduction from Baseline Visit in average targeted pain intensity at 3 months post-activation
Trial sites (7)
| Facility | City | Region | Status |
|---|---|---|---|
| Denver Back Pain Specialists | Greenwood | Colorado | Recruiting |
| Orlando Health Neuroscience Institute | Clermont | Florida | Recruiting |
| Ochsner Clinic Foundation | New Orleans | Louisiana | Recruiting |
| Montefiore Medical Center | The Bronx | New York | Recruiting |
| Fox Chase Pain Management | Trevose | Pennsylvania | Recruiting |
| PCPMG Clinical Research Unit, LLC | Greenville | South Carolina | Recruiting |
| Institute of Precision Pain Medicine | Corpus Christi | Texas | Recruiting |
More Boston Scientific Corporation trials in the USA
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07190807 on ClinicalTrials.gov ↗ ← All trials in the USA